Share：
Share this content in WeChat
X
[Chinese][PDF]1007131
• Clinical Article •
Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopy, and the combination of three techniques
LI Chun-mei  CHEN Min  LI Sa-ying  WANG Wen-chao  ZHAO Wei-feng  YANG Zheng-han  LIU Ming  ZHOU Cheng 

DOI:10.3969/j.issn.1674-8034.2010.04.004.


[Abstract] Objective: To evaluate T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), MR spectroscopy (MRS), and the combination of the three MR techniques in the diagnosis of prostate cancer, as correlation with histopathologic findings.Materials and Methods: MR imaging, including T2WI, DWI, and MRS, was performed at 1.5 T MR scanner with a body coil combined with a spine coil in 42 cases. Diagnosis was confirmed by histopathology through systematic transrectal prostate biopsy. All cases were evaluated by T2WI, DWI, MRS, and then by the three methods combined. The statistical indicators and the receiver operating characteristic (ROC) curve analysis of each method were compared to histopathological findings obtained by transrectal prostate biopsy.Results: Fifteen of 42 cases were confirmed to be cancerous, and 27 of 42 cases were noncancerous. All the 252 sextants were confirmed by biopsies, including 201 benign sextants and 51 malignant sextants. The sensitivity and the specificity for the detection of prostate cancer were 88.2% and 67.2% for T2WI, as the cutoff was 3; 82.4% and 81.6% for DWI, as the cutoff was 4; 84.3% and 98.0% for MRS, as the cutoff was 5; and 96.1% and 96.5% for the combined T2WI+DWI+MRS, as the cutoff was 4. In the ROC analysis, the correlative areas under the ROC curves (Az) were 0.848±0.030, 0.860±0.033, and 0.961±0.016 for T2WI, DWI, and MRS, respectively, and 0.978±0.009 for the combination of T2WI+DWI+MRS.Conclusion: Prostate cancer can be diagnosed effectively by T2WI, DWI and MRS separately. The diagnostic accuracy of prostate cancer is increased through a combination of the three techniques. Moreover, MRS demonstrated higher accuracy comparing with T2WI or DWI.
[Keywords] Prostate neoplasms；T2-weighted imaging；Diffusion-weighted imaging；Magnetic resonance spectroscopy

LI Chun-mei Department of Radiology, Beijing Hospital, Beijing 100730, China

CHEN Min* Department of Radiology, Beijing Hospital, Beijing 100730, China

LI Sa-ying Department of Radiology, Beijing Hospital, Beijing 100730, China

WANG Wen-chao Department of Radiology, Beijing Hospital, Beijing 100730, China

ZHAO Wei-feng Department of Radiology, Beijing Hospital, Beijing 100730, China

YANG Zheng-han Department of Radiology, Beijing Hospital, Beijing 100730, China

LIU Ming Department of Urology, Beijing Hospital, Beijing 100730, China

ZHOU Cheng Department of Radiology, Beijing Hospital, Beijing 100730, China

*Correspondence to: Chen M, E-mail: chenmin62@yahoo.com

Conflicts of interest   None.

Received  2010-06-15
Accepted  2010-07-05
DOI: 10.3969/j.issn.1674-8034.2010.04.004
DOI:10.3969/j.issn.1674-8034.2010.04.004.

[1]
Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin, 2007, 57(1): 43-66.
[2]
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics. CA Cancer J Clin, 2002, 55(2): 74-108.
[3]
Mescher M, Merkle H, Kirsch J, et al. Simultaneous in vivo spectral editing and water suppression. NMR Biomed, 1998, 11(6): 266-272.
[4]
Tanimoto A, Nakashima J, Kohno H, et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging, 2007, 25(2):146-152.
[5]
Wang XY, Zhou LP, Ding JP, et al. Quantitative criteria of MR spectroscopy in the differential diagnosis of prostate cancer in China: preliminary study. Chin J Med Imaging Technol, 2004, 20(8): 1150-1153.
[6]
Quint LE, Van Erp JS, Bland PH, et al. Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. Radiology, 1991, 179(3): 837-842.
[7]
Ikonen S, Karkkainen P, Kivisaari L, et al. Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dualecho, steady-state sequences. Eur Radiol, 2001, 11(2): 236-241.
[8]
Hosseinzadeh K, Schwarz SD. Endorectal diffusion weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging, 2004, 20(4): 654-661.
[9]
Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging, 2002, 16(2):196-200.
[10]
Pickles MD, Gibbs P, Sreenivas M, et al. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging. 2006, 23(2): 130-134.
[11]
Kurhanewicz J, Vigneron DB, Nelson SJ. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia, 2000, 2(2): 166-189.
[12]
Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on stepsection pathologic analysis after radical prostatectomy.Radiology, 2005, 234(3): 804-814.
[13]
Reinsberg SA, Payne GS, Riches SF, et al. Combined use of diffusion weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. Am J Roentgenol, 2007, 188(1): 91-98.
[14]
Tanimoto A, Nakashima J, Kohno H, et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging, 2007, 25(2): 146-152.
[15]
Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr, 2005, 29(2): 149-153.
[16]
Wefer AE, Hricak H, Vigneron DB, et al. Localization of prostate cancer: comparison of sextant biopsy,magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol, 2000, 164(2):400-404.
[17]
Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study. Radiology, 1999, 213(2): 473-480.

PREV MRI in clinical diagnosis and treatment of prostate cancer
NEXT MR imaging of incidentally detected prostate carcinoma in the central gland of prostate: preliminary study
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn